BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, today announced its participation in the 4th Annual ALS Drug Development Summit, to take ...

Neurological disorders such as Alzheimer’s and Parkinson’s may be linked to the brain’s reduced ability to clear harmful ...

The project is dedicated to safeguarding US vaccine use so that it remains grounded in the best available science, free from ...

Scientists have discovered that the same device used to measure C-reactive protein (CRP) in blood to diagnose bacterial ...

Hallucinations, cortical visual loss, advanced brain atrophy, and a normal CSF white blood cell count are tied to rapidly ...

While most patients clinically diagnosed with Alzheimer's had evidence of cerebrospinal fluid (CSF) amyloid and tau pathology ...

Researchers at Cedars-Sinai have made an important discovery: some patients who are diagnosed with a serious brain disease ...

Researchers have identified a biomarker in spinal fluid that can detect Parkinson’s disease in its early stages with over 90% ...

ALBANY — Albany Medical Center is participating in a clinical trial of the first minimally invasive option to treat normal ...

Belay Diagnostics, a CLIA/CAP accredited laboratory focused on the development and commercialization of molecular diagnostics targeting central nervous system (CNS) cancers, announced today the result ...

A new fluid biomarker for Parkinson’s disease (PD) was developed, offering a high-accuracy biological classification, ...